Skip to main content
icon for Measles cases in U.S. by August 31?

Measles cases in U.S. by August 31?

icon for Measles cases in U.S. by August 31?

Measles cases in U.S. by August 31?

BARU
Aug 31, 2026
Polymarket

$637 Vol.

Polymarket

2400+

$472 Vol.

98%

2450+

$125 Vol.

93%

2500+

$0 Vol.

83%

2550+

$29 Vol.

66%

2600+

$10 Vol.

56%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained community transmission among largely unvaccinated populations continues to drive elevated U.S. measles incidence, with the CDC reporting 2,371 confirmed cases through July 30, 2026—already exceeding the 2025 full-year total of 2,289. Most cases (94%) are outbreak-associated, concentrated in jurisdictions with low MMR coverage, while importation events remain limited. Official surveillance data reflect confirmed reports only, with potential undercounting due to variable state-level detection. Key variables for August accumulation include ongoing outbreak containment, seasonal travel patterns, and any shifts in vaccination uptake or public health interventions ahead of CDC's weekly updates. Historical precedent shows rapid case growth possible in under-immunized clusters before resolution thresholds are assessed.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$637
Tanggal Berakhir
Aug 31, 2026
Pasar Dibuka
Jul 31, 2026, 10:25 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained community transmission among largely unvaccinated populations continues to drive elevated U.S. measles incidence, with the CDC reporting 2,371 confirmed cases through July 30, 2026—already exceeding the 2025 full-year total of 2,289. Most cases (94%) are outbreak-associated, concentrated in jurisdictions with low MMR coverage, while importation events remain limited. Official surveillance data reflect confirmed reports only, with potential undercounting due to variable state-level detection. Key variables for August accumulation include ongoing outbreak containment, seasonal travel patterns, and any shifts in vaccination uptake or public health interventions ahead of CDC's weekly updates. Historical precedent shows rapid case growth possible in under-immunized clusters before resolution thresholds are assessed.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$637
Tanggal Berakhir
Aug 31, 2026
Pasar Dibuka
Jul 31, 2026, 10:25 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Hati-hati dengan link eksternal.

Pertanyaan yang Sering Diajukan

"Measles cases in U.S. by August 31?" adalah pasar prediksi di Polymarket dengan 5 hasil yang mungkin di mana trader membeli dan menjual saham berdasarkan apa yang mereka yakini akan terjadi. Hasil terdepan saat ini adalah "2400+" di 98%, diikuti oleh "2450+" di 93%. Harga mencerminkan probabilitas crowd-sourced real-time. Misalnya, saham yang dihargai 98¢ menyiratkan bahwa pasar secara kolektif memberikan peluang 98% pada hasil tersebut. Peluang ini bergeser terus-menerus saat trader bereaksi terhadap perkembangan dan informasi baru. Saham dengan hasil yang benar bisa ditukarkan seharga $1 setiap saham saat pasar diselesaikan.

"Measles cases in U.S. by August 31?" adalah pasar yang baru dibuat di Polymarket, diluncurkan pada Jul 31, 2026. Sebagai pasar awal, ini adalah kesempatanmu untuk menjadi salah satu trader pertama yang menetapkan peluang dan membangun sinyal harga awal pasar. Kamu juga bisa menandai halaman ini untuk melacak volume dan aktivitas trading seiring pasar mendapatkan traksi.

Untuk trading di "Measles cases in U.S. by August 31?," jelajahi 5 hasil yang tersedia di halaman ini. Setiap hasil menampilkan harga saat ini yang mewakili probabilitas tersirat pasar. Untuk mengambil posisi, pilih hasil yang menurutmu paling mungkin, pilih "Ya" untuk mendukungnya atau "Tidak" untuk menentangnya, masukkan jumlahmu, dan klik "Trade." Jika hasil pilihanmu benar saat pasar diselesaikan, saham "Ya" kamu membayar $1 masing-masing. Jika salah, mereka membayar $0. Kamu juga bisa menjual sahammu kapan saja sebelum resolusi jika kamu ingin mengamankan keuntungan atau memotong kerugian.

Unggulan saat ini untuk "Measles cases in U.S. by August 31?" adalah "2400+" di 98%, yang berarti pasar memberikan peluang 98% pada hasil tersebut. Hasil terdekat berikutnya adalah "2450+" di 93%. Peluang ini diperbarui secara real-time saat trader membeli dan menjual saham, sehingga mencerminkan pandangan kolektif terbaru tentang apa yang paling mungkin terjadi. Cek kembali secara rutin atau tandai halaman ini untuk mengikuti bagaimana peluang bergeser saat informasi baru muncul.

Aturan resolusi untuk "Measles cases in U.S. by August 31?" mendefinisikan dengan tepat apa yang harus terjadi agar setiap hasil dinyatakan sebagai pemenang — termasuk sumber data resmi yang digunakan untuk menentukan hasilnya. Kamu bisa meninjau kriteria resolusi lengkap di bagian "Aturan" di halaman ini di atas komentar. Kami menyarankan membaca aturan dengan cermat sebelum trading, karena mereka menentukan kondisi tepat, kasus khusus, dan sumber yang mengatur bagaimana pasar ini diselesaikan.